Loading...
XASXCDX
Market cap26mUSD
Jan 09, Last price  
0.11AUD
1D
5.00%
1Q
81.03%
Jan 2017
-84.57%
IPO
-98.65%
Name

CardieX Ltd

Chart & Performance

D1W1MN
XASX:CDX chart
P/E
—
P/S
3.90
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
24.18%
Rev. gr., 5y
22.79%
Revenues
11m
+136.86%
3,106,0003,334,0004,874,0006,450,59911,209,1139,198,4967,458,4506,441,4939,055,7215,053,2845,467,4575,019,3874,327,2834,006,0913,907,0934,292,5525,001,1344,066,9824,604,28410,905,636
Net income
-7m
L-64.51%
-2,696,000-4,005,000-5,183,000-3,792,731-1,691,433-1,220,057-3,081,084-1,985,5192,734,023-2,663,508-1,440,177-4,805,892-4,363,571-2,961,225-2,979,278-3,320,427-5,545,597-11,383,382-19,063,305-6,765,365
CFO
-8m
L-35.63%
-2,454,000-4,267,000-4,488,000-3,778,473-637,556-2,578,551-1,895,004-1,182,3221,776,662-1,363,948-1,965,647-4,920,151-3,065,630-207,494-2,290,773-1,698,851-3,972,794-9,617,376-11,996,350-7,721,600
Earnings
Feb 26, 2025

Profile

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
URL
https://cardiex.com/
IPO date
Nov 09, 2005
Employees
26
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
10,906
136.86%
4,604
13.21%
4,067
-18.68%
Cost of revenue
17,421
21,053
16,708
Unusual Expense (Income)
NOPBT
(6,515)
(16,449)
(12,641)
NOPBT Margin
Operating Taxes
(873)
1,048
1,281
Tax Rate
NOPAT
(5,642)
(17,497)
(13,921)
Net income
(6,765)
-64.51%
(19,063)
67.47%
(11,383)
105.27%
Dividends
Dividend yield
Proceeds from repurchase of equity
7,327
9,378
7,454
BB yield
-52.19%
-46.50%
-20.89%
Debt
Debt current
3,387
3,806
1,420
Long-term debt
1,111
1,135
1,421
Deferred revenue
Other long-term liabilities
9
6
2
Net debt
(1,246)
(1,844)
(4,258)
Cash flow
Cash from operating activities
(7,722)
(11,996)
(9,617)
CAPEX
(118)
(80)
(438)
Cash from investing activities
(118)
(80)
(438)
Cash from financing activities
7,592
11,352
7,414
FCF
(4,878)
(18,743)
(14,639)
Balance
Cash
5,352
6,274
2,499
Long term investments
393
510
4,601
Excess cash
5,199
6,554
6,896
Stockholders' equity
4,087
(1,001)
6,244
Invested Capital
3,872
4,313
2,439
ROIC
ROCE
EV
Common stock shares outstanding
200,551
130,111
115,125
Price
0.07
-54.84%
0.16
-50.00%
0.31
-56.34%
Market cap
14,039
-30.39%
20,167
-43.49%
35,689
-48.47%
EV
12,792
18,323
31,430
EBITDA
(6,288)
(16,223)
(12,318)
EV/EBITDA
Interest
1,183
351
228
Interest/NOPBT